Industry says speed-within-market is as important as speed-to-market
Tufts Center for the Study of Drug Development Impact R E P O RT
Download full article here:cross-functional-teams-key-to-project-success-tufts-center.pdf
June xx, 1999 ANALYSIS AND INSIGHT INTO CRITICAL DRUG DEVELOPMENT ISSUES
Average annual new drug approvals in the U.S. doubled from the 1970s to the 1990s while R&D costs more than quintupled.
Forecasting scientific needs provides a tool for managing the gap between potential projects and available resources.
Development projects should aim for full commercialization of a new product, not just regulatory filing.
Marketing and sales activity ideally should start 2-3 years before product launch.
Information technology, yet to be fully deployed in servicing existing and emerging markets, will be decisive in integrating R&D with commercial activity.
Cross-functional teams focused on patient markets enable portfolio management for a single compound.
